Cardlytics, Inc. 8-K

What Happened

• Cardlytics, Inc. announced it completed the sale (the "Bridg Sale") of its Bridg platform assets on March 24, 2026. The sale was made to DB Sub, LLC, an indirectly wholly owned subsidiary of PAR Technology Corporation (PAR).
• Under the Purchase Agreement dated January 23, 2026, Cardlytics received 1,810,222 shares of PAR common stock as consideration for the Bridg Sale. The company filed the transaction under Item 1.01 and Item 2.01 on Form 8-K and included unaudited pro forma condensed consolidated financial statements as Exhibit 99.1 (Item 9.01).

Key Details

• Closing Date: March 24, 2026; Purchase Agreement effective January 23, 2026 (previously disclosed on a prior Form 8-K filed Jan 26, 2026).
• Buyer: DB Sub, LLC (indirectly wholly owned by PAR Technology Corporation).
• Consideration: 1,810,222 shares of PAR’s common stock delivered to Cardlytics at closing.
• Pro forma impact: Cardlytics filed unaudited pro forma condensed consolidated financial statements reflecting the disposition (Exhibit 99.1).

Why It Matters

• This is a material disposition of Cardlytics’ Bridg platform assets, which will change the company’s asset base and could affect future revenue and operating results related to the Bridg business.
• Instead of cash, Cardlytics received PAR stock, leaving the company with equity exposure to PAR rather than direct cash proceeds—important for assessing liquidity and potential future gains or risks.
• The filed unaudited pro forma financials provide investors with the company’s view of how the disposition affects its consolidated results and should be reviewed to understand near-term financial impacts.